The US FDA have revoked an EUA given to Chembio for its COVID-19 serology test. Data submitted by Chembio and an independent study found the DPP COVID-19 IgM/IgG System showed a higher rate of false results that outweighed it's benefit to COVID-19 testing regimes. 
Find Out More

The China National Medical Products Administration (NMPA) are constantly updating their 'allowed list' of COVID-19 test kit vendors who they have given approval for export. You can download the most recent list here. 
Find Out More

Developed by ProGnosis Biotech, the Rapid Test 2019-nCoV Total Ig demonstrated 98.75% sensitivity and 100% specificity for total antibodies against SARS-CoV-2 in the latest clinical performance study.
Find Out More

PCR Biosystems' 4x RT-qPCR kit enables ultra-sensitive, high-throughput detection of viral RNA sequences, the new kit allows users to add more sample to their reactions to boost analytical sensitivity, even when working with small volume reactions.
Find Out More

Chromacode's high-definition multiplex technology is now used to detect SARS-CoV-2. The HDPCR™ SARS-CoV-2 Real-Time PCR Assay is now FDA-EUA, allows high-throughput testing, and runs on standard qPCR instruments with no on-site training required. 
Find Out More

Adding to its ever-expanding COVID-19 portfolio which includes recombinant proteins, antibodies, inhibitor screening kits, ​AMSBIO has launched a new range of SARS-CoV-2 Spike Protein Products to be used in immunocapture, cell-stimulating, flow cytometry applications, ELISA assays and biopanning.
Find Out More

Quidel's Sofia® SARS Antigen FIA, the first FDA-Emergency Use Authorized COVID-19 Antigen test, is now allowed to run on both of Quidel's Point-of-Care instruments; the Sofia 1 & 2. The instruments provide a result within 15 minutes. 
Find Out More

Flowbot ONE, a Danish designed robot is becoming popular in Europe and Australia, where clinical laboratories are putting it to use in manipulating multiple live samples of SARS-CoV-2 simultaneously for analysis, potentially removing risk to personnel and error from the process. 
Find Out More

LGC SeraCare has launched AccuSet™ SARS-CoV-2 Performance Panel; an out-of-the-box solution to provide confidence, mitigate sourcing challenges and accelerate antibody assay development, validation, verification, and onboarding. 
Find Out More

As the world moves into the next phase of COVID-19 pandemic control the challenging task of re-opening public spaces without compromising public safety requires science-based surety. Bertin Technologies can help with the Coriolis Air Sampler + RT-PCR platform that collects and detects SARS-CoV-2.
Find Out More